Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Banyu claims farnesyltransferase inhibitors

July 11, 1997

New antitumor taxanes from Yakult Honsha

July 11, 1997

Hycamtin launched in Canada

July 10, 1997

Kyowa Hakko develops cell adhesion inhibitors

July 10, 1997

Immunex receives approval to market paclitaxel in Canada

July 9, 1997

Novel antitumor agents from Sanwa Kagaku

July 9, 1997

CarboMed licenses broad-spectrum anticancer agent to Zeneca

July 8, 1997

QLT PhotoTherapeutics files for Canadian approval of lung cancer treatment

July 8, 1997

MRC initiates trial to improve survival of patients with resectable NSCLC

July 8, 1997

Troponin I inhibits breast cancer growth in preclinical trial

July 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...